Intuitive Surgical Stock News

These stocks are poised for long-term success regardless of how this year unfolds.

COVID-19 has slowed down growth, but long-term prospects look very promising.

COVID-19 has slowed down growth, but long-term prospects look very promising.

Could health care stocks be back in focus amid market volatility?

While they are slightly pricey now, these stocks have some incredible growth potential.

A well-balanced diversified portfolio is fruitful in the long run.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09 in the year-ago quarter. At

Intuitive Surgical (ISRG) is trading ~2% higher in the pre-market after UBS upgraded the maker of da Vinci robotic surgical systems to Buy from Neutral, citing a compelling entry

A well-balanced diversified portfolio is fruitful in the long run.

"Mad Money" host Jim Cramer explained Tuesday why he expects to see a bounce back in shares of Edwards Lifesciences, Intuitive Surgical and Stryker.

"I think there are some true steals are developing in the medical device space because of omicron," the "Mad Money" host said.

The stock market sell-off can be a golden opportunity for discerning investors.

Macroeconomic conditions have shocked the market thus far in 2022. While some investors are running for the hills, others are looking for opportunities.

US Futures Start The Week With More Wild Swing In Another Volatile, Illiquid Session After a rollercoaster week that ended just barely higher following a late meltup on Friday, overnight volatile US stock futures swung to start the week, with Nasdaq 100 futures leading gains after rallying on Friday, before turning red and threatening to fizzle a global equity rally amid persistent worries over the Federal Reserve’s plan to hike interest rates this year. Emini S&P futures were down 0.5% or 21 points to 4401, after rising as high as 4437 and dropping as low as 4395 in another extremely illiquid session where China being offline for the week due to Lunar New Year did not help; Nasdaq futures were down 0.1% while Dow futures were lower 0.7%. Technology stocks led gains on the Stoxx Europe 600. Meanwhile, the dollar fell and oil rallied. As investors reconcile to a hawkish U.S. central bank coupled with strong earnings, the expensive parts of the U.S. stock market are undergoing a valuation re-rating along with the bond markets.